Chester County News and Community Website
WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) has released its 2024 financial results and provided an update on its clinical pipeline, underscoring significant progress in its precision oncology programs. The …
Prelude Therapeutics Reports 2024 Financial Results and Clinical Pipeline Advancements Read More
HAVERTOWN, PA — AMREP Corporation (NYSE: AXR) announced a marked improvement in financial performance for its fiscal third quarter ending January 31, 2025, and the first nine months of the …
AMREP Corporation Reports Strong Q3 and Nine-Month Financial Results Read More
WILMINGTON, DE — Acorn Energy, Inc. (OTCQB: ACFN) has announced its financial results for the fourth quarter and full year of 2024, highlighting significant growth in revenue, net income, and …
Acorn Energy Reports Strong 2024 Results, Plans Nasdaq Uplisting Read More
EXTON, PA — Dean W. Rivest, CEO of Omega Flex, Inc. (Nasdaq: OFLX), reported that the company’s net sales for 2024 totaled $101,681,000, compared to $111,465,000 in 2023, reflecting a …
Omega Flex Reports 2024 Financial Results: Sales and Income Decline Amid Market Challenges Read More
YARDLEY, PA — Smart Sand, Inc. (NASDAQ: SND) has announced its financial results for the fourth quarter and full year 2024, showcasing record-breaking sales volumes, strong revenue growth, and strategic milestones, …
Smart Sand Reports Record Volumes and Strong 2024 Financial Results Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has reported its fourth-quarter and full-year 2024 financial results, alongside significant progress across its clinical programs and regulatory initiatives. The company continues to drive …
Ocugen Reports 2024 Financial Results and Advances Gene Therapy Programs Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has released its 2024 financial results, detailing significant operational progress and strategic milestones, including the acquisition of Greenbrook TMS, FDA clearance for adolescent …
Neuronetics Reports 2024 Financial Results and Strategic Advances Read More
PHILADELPHIA, PA — Passage Bio, Inc. (NASDAQ: PASG) announced its 2024 financial results, highlighting progress in its PBFT02 gene therapy program for frontotemporal dementia (FTD) associated with GRN mutations (FTD-GRN) …
Passage Bio Reports 2024 Financial Results and Advances in PBFT02 Program Read More
NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (NASDAQ: AVBP) announced its 2024 financial results, showcasing significant progress in clinical programs and pipeline expansion. The company highlighted substantial milestones achieved over …
ArriVent BioPharma Reports 2024 Financial Results and Key Achievements Read More
WYOMISSING, PA — PENN Entertainment, Inc. (Nasdaq: PENN) announced its 2024 financial results, highlighting steady revenue growth, strong property-level performance, and advancements in its Interactive segment. The company’s focus on strategic …
PENN Entertainment Reports Solid 2024 Financial Results, Eyes Growth in 2025 Read More